Showing 221 - 240 results of 473 for search '(( significant decrease decrease ) OR ( significant ((non decrease) OR (mean decrease)) ))~', query time: 0.59s Refine Results
  1. 221
  2. 222
  3. 223

    GWAS analysis identifies several single nucleotide polymorphisms (SNPs) that are associated with the changes in viral copies. by Ke Li (106849)

    Published 2024
    “…(C) The corresponding synonymous (triangles) and non-synonymous (circles) amino acid changes that associate with increased or decreased viral copies. …”
  4. 224

    GWAS analysis identifies several single nucleotide polymorphisms (SNPs) that are associated with the changes in viral copies. by Ke Li (106849)

    Published 2024
    “…(C) The corresponding synonymous (triangles) and non-synonymous (circles) amino acid changes that associate with increased or decreased viral copies. …”
  5. 225
  6. 226
  7. 227
  8. 228
  9. 229
  10. 230
  11. 231
  12. 232
  13. 233
  14. 234

    Adverse event list. by Stefan Halbherr (21353882)

    Published 2025
    “…Some patients reported mild dizziness for a few hours after TLN following many but not all administrations throughout the study.</p><p>Non-motor symptoms of PD, motor parkinsonian signs off medication, and quality of life improved significantly during the treatment phase, including the MDS-UPDRS total score (mean decrease −11.09; 95% Confidence Interval [CI]; −18, −4.1; <i>p</i> = 0.006), the Parkinson’s disease Questionnaire-39 (PDQ-39) summary index (mean decrease −2.91; 95% CI; −4.4, −1.4; <i>p</i> = 0.005), and the Non-Motor Symptoms Questionnaire (NMS-Quest) (mean decrease −4.27; 95% CI; −6.5, −2.1; <i>p</i> = 0.009). …”
  15. 235

    Patient characteristics. by Stefan Halbherr (21353882)

    Published 2025
    “…Some patients reported mild dizziness for a few hours after TLN following many but not all administrations throughout the study.</p><p>Non-motor symptoms of PD, motor parkinsonian signs off medication, and quality of life improved significantly during the treatment phase, including the MDS-UPDRS total score (mean decrease −11.09; 95% Confidence Interval [CI]; −18, −4.1; <i>p</i> = 0.006), the Parkinson’s disease Questionnaire-39 (PDQ-39) summary index (mean decrease −2.91; 95% CI; −4.4, −1.4; <i>p</i> = 0.005), and the Non-Motor Symptoms Questionnaire (NMS-Quest) (mean decrease −4.27; 95% CI; −6.5, −2.1; <i>p</i> = 0.009). …”
  16. 236

    Table 1_Glucose and lipid metabolism in non-diabetic, non-obese patients with obstructive sleep apnea: sex differences.docx by Yuhan Wang (595964)

    Published 2025
    “…The high-density lipoprotein cholesterol (HDL-C) level in OSA participants was significantly lower (0.99 vs. 1.12 mmol/L, p = 0.036), and the triglyceride-glucose (TyG) index was significantly higher (8.74 vs. 8.45, p = 0.016), while there was no significant difference in the levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and non-HDL-C. …”
  17. 237

    Multiple comparisons after ANOVA(CR10). by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  18. 238

    Homogeneity test of CR10. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  19. 239

    Illustration of the fNIRS device worn. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  20. 240

    Analysis of variance of HbO<sub>2</sub> in bilateral PFC. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”